TCRCure Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 70
Employees
  • Latest Deal Type
  • Series B
  • Investors
  • 5

TCRCure General Information

Description

Developer of cancer immunotherapies that focuses on streamlined biotechnology development, including high throughput antigen-specific TCR (T cell antigen receptor) cloning, industry scale virus production, T cell genetic engineering, and immune cell manufacturing.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Building 12, No.6, Nanjiang Second R, Zhujiang Street
  • Nansha District
  • Guangzhou, Guangdong
  • China
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TCRCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 02-Apr-2019 Completed Generating Revenue
2. Early Stage VC (Series A) 03-Dec-2018 Completed Generating Revenue
1. Seed Round 03-Aug-2016 Completed Startup
To view TCRCure’s complete valuation and funding history, request access »

TCRCure Executive Team (1)

Name Title Board Seat Contact Info
Qijing Li Ph.D Founder & Chief Scientific Officer
To view TCRCure’s complete executive team members history, request access »

TCRCure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TCRCure Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Emerging Technology Partners Venture Capital Minority 000 0000 000000 0
Share Capital Venture Capital Minority 000 0000 000000 0
Fang Fund Partners Venture Capital Minority 000 0000 000000 0
Jiadao Valley Investment Venture Capital Minority 000 0000 000000 0
In Capital Asset Manager Minority 000 0000 000000 0
To view TCRCure’s complete investors history, request access »